# OnCo record nct06760819 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06760819/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06760819", "NCT06760819" ;
  schema:name "A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)"@en ;
  schema:alternateName "panSOHO"@en ;
  schema:description "A phase 2 trial of BAY2927088 in advanced solid tumours, run by Bayer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06760819/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06760819> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-02-13" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/bayer/> .